Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 6 studies | 76% ± 23% | |
| endothelial cell | 3 studies | 30% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 49% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 107926.43 | 226 / 226 | 96% | 710.10 | 388 / 406 |
| kidney | 98% | 543.00 | 87 / 89 | 30% | 1.37 | 269 / 901 |
| spleen | 100% | 263.52 | 241 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 80% | 26.43 | 206 / 258 | 13% | 0.84 | 30 / 230 |
| intestine | 55% | 24.83 | 536 / 966 | 28% | 1.31 | 149 / 527 |
| adipose | 76% | 40.19 | 915 / 1204 | 0% | 0 | 0 / 0 |
| breast | 70% | 33.80 | 321 / 459 | 4% | 0.53 | 41 / 1118 |
| stomach | 49% | 7.69 | 175 / 359 | 22% | 0.49 | 62 / 286 |
| pancreas | 52% | 9.94 | 169 / 328 | 13% | 0.77 | 23 / 178 |
| prostate | 59% | 11.58 | 145 / 245 | 2% | 0.02 | 8 / 502 |
| peripheral blood | 47% | 139.37 | 436 / 929 | 0% | 0 | 0 / 0 |
| bladder | 33% | 3.90 | 7 / 21 | 11% | 0.27 | 55 / 504 |
| uterus | 36% | 6.87 | 61 / 170 | 7% | 0.35 | 34 / 459 |
| lung | 39% | 7.21 | 226 / 578 | 4% | 0.16 | 43 / 1155 |
| esophagus | 33% | 7.14 | 477 / 1445 | 8% | 0.18 | 14 / 183 |
| ovary | 39% | 5.58 | 71 / 180 | 1% | 0.26 | 3 / 430 |
| skin | 28% | 6.69 | 513 / 1809 | 4% | 0.31 | 17 / 472 |
| thymus | 30% | 6.08 | 199 / 653 | 0% | 0.02 | 3 / 605 |
| blood vessel | 26% | 6.77 | 350 / 1335 | 0% | 0 | 0 / 0 |
| heart | 25% | 5.36 | 216 / 861 | 0% | 0 | 0 / 0 |
| muscle | 21% | 2.80 | 171 / 803 | 0% | 0 | 0 / 0 |
| brain | 18% | 2.63 | 473 / 2642 | 2% | 0.06 | 12 / 705 |
| eye | 0% | 0 | 0 / 0 | 15% | 0.25 | 12 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007219 | Biological process | Notch signaling pathway |
| GO_0046724 | Biological process | oxalic acid secretion |
| GO_0019265 | Biological process | glycine biosynthetic process, by transamination of glyoxylate |
| GO_0042853 | Biological process | L-alanine catabolic process |
| GO_0046487 | Biological process | glyoxylate metabolic process |
| GO_0019448 | Biological process | L-cysteine catabolic process |
| GO_0009436 | Biological process | glyoxylate catabolic process |
| GO_0006563 | Biological process | L-serine metabolic process |
| GO_0005777 | Cellular component | peroxisome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005782 | Cellular component | peroxisomal matrix |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0030170 | Molecular function | pyridoxal phosphate binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0008453 | Molecular function | alanine-glyoxylate transaminase activity |
| GO_0016597 | Molecular function | amino acid binding |
| GO_0004760 | Molecular function | serine-pyruvate transaminase activity |
| GO_0008483 | Molecular function | transaminase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | AGXT |
| Protein name | Alanine--glyoxylate aminotransferase (AGT) (SPT) (EC 2.6.1.44) (EC 2.6.1.51) (Serine--pyruvate aminotransferase) Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44) (Serine--pyruvate aminotransferase) (SPT) (EC 2.6.1.51) |
| Synonyms | AGT1 SPAT |
| Description | FUNCTION: Peroxisomal aminotransferase that catalyzes the transamination of glyoxylate to glycine and contributes to the glyoxylate detoxification . Also catalyzes the transamination between L-serine and pyruvate and contributes to gluconeogenesis from the L-serine metabolism . . |
| Accessions | ENST00000307503.4 A2V838 P21549 |